EW vs SOLV · P/E 47, rev $1.39B vs P/E 9.1, rev $8.25B
Edwards Lifesciences Corp (EW) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the EW and SOLV stock pages for the full models.
Not investment advice.